Interview: Ernest Bartosik, Country Manager, Unipharm, Poland
Unipharm Poland’s country manager explains what is needed to become a successful OTC and dietary supplement company in Poland, saying that it is “key to master the marketing mix but…
Unipharm is an American pharmaceutical company specializing in the development and marketing of quality over-the-counter (OTC) drugs and nutritional products. Since it was established in the USA in 1992, the Company has consistently grown, and continues to provide award-winning, quality products to its loyal customers in many different countries.
Unipharm has been for many years registered with the US Food and Drug Administration. All of Unipharm’s products are made in the USA under extensive quality control supervision at well-established facilities that follow Good Manufacturing Practice (GMP) guidelines and United States Pharmacopeia (USP) standards. We are also proud to be certified by National Sanitation Foundation (NSF) International. In addition, our products are manufactured, tested and packaged according to regulations mandated by every country the Company sells in.
The world headquarters of Unipharm is located here in the Empire State Building in New York City, and there are many branch offices worldwide. Unipharm products are successful, both in terms of brand awareness and sales, and this is demonstrated by the kind of loyalty that you, our loyal customers, demonstrate to us. The Company is committed to continue offering a wide variety of quality goods that are both safe and effective.
In Poland Unipharm’s offer is dedicated to physicians, their patients, and consumers in area of joint care, bone health, osteoporosis, beauty, aging, memory loss and immune support. The Company is deeply engaged in both health education and activities which support healthy life, medical prophylaxis and treatment.
Unipharm Poland’s country manager explains what is needed to become a successful OTC and dietary supplement company in Poland, saying that it is “key to master the marketing mix but…
“We have made some progress in terms of the conceptualization of depression as a disease. Previously, the popular attitude was that depression was a temporary emotion; one that could be…
IMS’ General Manager, Maciej Kuzmierkiewicz, discusses the effects of the Reimbursement Act—the new legislative framework implemented in January 2012—which completely reshaped the rules of the game for the Polish pharmaceutical sector…
You have been heading the affiliate since its creation in 1997; therefore you saw its evolution and growth. Would you say that Apotex Poland has evolved in accordance with the…
You have been heading the affiliate since its creation in 1997; therefore you saw its evolution and growth. Would you say that Apotex Poland has evolved in accordance with the…
You have been quite recently appointed at the head of the Polish affiliate of AstraZeneca. With which personal ambitions did you come and what was the mission you were given…
The pharmaceutical industry market growth, including generics and originator drugs, is today steady and sustainable. The market size is over 5 billion Euros which makes Poland the 6th biggest market…
You were appointed general manager of Astellas Poland in early 2006, only a bit after Astellas Pharma Inc. was established, on April 1, 2005 through the merger of the mother…
BAUSCH + LOMB has over 150 years of heritage and has always been associated with optics and ophthalmology. Therefore the company has been able to build a very strong brand…
Given Cegedim’s global reach and your 13 year experience of operating as a consultant to the Polish pharma industry, how would you describe the market to the international readers of…
As Squibb Corporation and Bristol-Myers merged in 1989, Bristol-Myers Squibb has been officially operating in this market since that date, but the affiliate has a long history previous to that.…
The pharmaceutical industry market growth, including generics and originator drugs, is today steady and sustainable, approximating 10% year on year. The market size is over five billion Euros which makes…
In the pharma world, managers change frequently from one company to another, and this phenomenon has been accelerated with the consolidation of the market, however you chose to dedicate your…
See our Cookie Privacy Policy Here
